Virus nuclear import

Advanced Drug Delivery Reviews

Volumn 55, Issue 6, 2003, Pages 733-747

  Whittaker, Gary R ^a  

^a Animal Health Diagnostic Center   (United States)

Author keywords

Herpesvirus; HIV; Influenza; Nuclear targeting; Nuclear transport; Viral infection

Indexed keywords

BIOLOGICAL MEMBRANES; CELLS; GENES; PORE SIZE;

NUCLEAS;

VIRUSES;

AMANTADINE; ANTIVIRUS AGENT; CELL NUCLEUS DNA; CELL SURFACE RECEPTOR; CNIH 0292; CNIH 1194; CYSTEINE PROTEINASE; FIBRONECTIN; GAG PROTEIN; HEAT SHOCK PROTEIN 90; IMMUNOGLOBULIN; INTEGRASE; INTEGRIN; KARYOPHERIN ALPHA; KARYOPHERIN BETA; PHOSPHOLIPASE A; PROTEIN KINASE C; PROTEIN SUBUNIT; PROTEIN VP1; RAN PROTEIN; RIBONUCLEOPROTEIN; RIMANTADINE; UNCLASSIFIED DRUG; VIRUS DNA; VPR PROTEIN;

ADENOVIRUS; CAVEOLA; CELL COMPARTMENTALIZATION; CELL DIVISION; CELL MEMBRANE; CELL NUCLEUS; CELL NUCLEUS MEMBRANE; CELL SIZE; CELL SURFACE; CELL TRANSPORT; CHROMATIN; CYTOPLASM; DNA VIRUS; ENDOCYTOSIS; ENDOSOME; EUKARYOTIC CELL; HEPADNAVIRUS; HERPES VIRUS; HOST CELL; HOST PATHOGEN INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INFLUENZA VIRUS; INTEGUMENT; MICROBIAL KINETICS; MITOSIS; NONHUMAN; NUCLEAR IMPORT; NUCLEAR LOCALIZATION SIGNAL; NUCLEAR PORE; PAPOVAVIRUS; PARVOVIRUS; PH; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN NUCLEIC ACID INTERACTION; PROTEIN PHOSPHORYLATION; REVIEW; RNA VIRUS; SIGNAL TRANSDUCTION; VIRION; VIRUS ASSEMBLY; VIRUS CAPSID; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS INFECTION; VIRUS REPLICATION;

EID: 0038699054     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(03)00051-6     Document Type: Review

References (128)

1. Whittaker G.R., Helenius A. Nuclear import and export of viruses and virus genomes. Virology. 246:1998;1-23.
2. Rout M.P., Aitchison J.D. The nuclear pore complex as a transport machine. J. Biol. Chem. 276:2001;16593-16596.
3. Wente S.R. Gatekeepers of the nucleus. Science. 288:2000;1374-1377.
4. Dworetzky S.I., Feldherr C.M. Translocation of RNA-coated gold particles through the nuclear pores at oocytes. J. Cell Biol. 106:1988;575-584.
5. Dworetzky S.I., Lanford R.E., Feldherr C.M. The effects of variations in the number and sequence of targeting signals on nuclear uptake. J. Cell Biol. 107:1988;1279-1287.
6. Pante N., Kann M. Nuclear pore complex is able to transport macromolecules with diameters of about 39 nm. Mol. Biol. Cell. 13:2002;425-434.
7. Gorlich D., Kutay U. Transport between the cell nucleus and the cytoplasm. Annu. Rev. Cell Dev. Biol. 15:1999;607-660.
8. Nakielny S., Dreyfuss G. Transport of proteins and RNAs in and out of the nucleus. Cell. 99:1999;677-690.
9. Macara I.G. Transport into and out of the nucleus. Microbiol. Mol. Biol. Rev. 65:2001;570-594.
10. Bergelson J.M., et al. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science. 275:1997;1320-1323.
11. Wickham T.J., Mathias P., Cheresh D.A., Nemerow G.R. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell. 73:1993;309-319.
12. Chardonnnet Y., Dales S. Early events in the interaction of adenoviruses with HeLa cells. I. Penetration of type 5 and intracellular release of the DNA genome. Virology. 40:1970;462-477.
13. Greber U.F., Singh I., Helenius A. Mechanisms of virus uncoating. Trends Microbiol. 2:1994;52-56.
14. Pastan I., Seth P., FitzGerald D., Willingham M. Adenovirus entry into cells: some new observations on an old problem. Notkins A.L., Oldstone M.B.A. Concepts in Viral Pathogenesis II. 1986;Springer Verlag, New York.
15. Wickham T.J., Filardo E.J., Cheresh D.A., Nemerow G.R. Integrin alpha v beta 5 selectively promotes adenovirus mediated cell membrane permeabilization. J. Cell Biol. 127:1994;257-264.
16. Greber U.F., Willetts M., Webster P., Helenius A. Stepwise dismantling of adenovirus 2 during entry into cells. Cell. 75:1993;477-486.
17. Cotten M., Weber J.M. The adenovirus protease is required for virus entry into host cells. Virology. 213:1995;494-502.
18. Greber U.F., Webster P., Weber J., Helenius A. The role of the adenovirus protease on virus entry into cells. EMBO J. 15:1996;1766-1777.
19. Miyazawa N., Crystal R.G., Leopold P.L. Adenovirus serotype 7 retention in a late endosomal compartment prior to cytosol escape is modulated by fiber protein. J. Virol. 75:2001;1387-1400.
20. Suomalainen M., Nakano M.Y., Keller S., Boucke K., Stidwell R.P., Greber U.J. Microtubule-dependent plus- and minus end-directed motilities are competing processes for nuclear targeting of adenovirus. Cell Biol. 144:1999;657-672.
21. Suomalainen M., Nakano M.Y., Boucke K., Keller S., Greber U.F. Adenovirus-activated PKA and p38/MAPK pathways boost microtubule-mediated nuclear targeting of virus. EMBO J. 20:2001;1310-1319.
22. Glotzer J.B., Michou A.I., Baker A., et al. Microtubule-independent motility and nuclear targeting of adenoviruses with fluorescently labeled genomes M. J. Virol. 75:2001;2421-2434.
23. Morgan C., Rosenkranz H.S., Mednis B.J. Structure and development of viruses as observed in the electron microscope. V. Entry and uncoating of adenovirus. Virology. 4:1969;777-796.
24. Greber U.F., Suomalainen M., Stidwell R.P., Boucke K., Ebersold M.W., Helenius A. The role of the nuclear pore complex in adenovirus DNA entry. EMBO J. 16:1997;5998-6007.
25. Saphire A.C.S., Guan T., Schirmer E.C., Nemerow G.R., Gerace L. Nuclear import of adenovirus DNA in vitro involves the nuclear protein import pathway and hsc70. J. Biol. Chem. 275:2000;4298-4304.
26. Wisnivesky J.P., Leopold P.L., Crystal R.G. Specific binding of the adenovirus capsid to the nuclear envelope. Hum. Gene Ther. 10:1999;2187-2195.
27. Trotman L.C., Mosberger N., Fornerod M., Stidwill R.P., Greber U.F. Import of adenovirus DNA involves the nuclear pore complex receptor CAN/Nup214 and histone H1. Nat. Cell Biol. 3:2001;1092-1100.
28. Monahan P.E., Samulski R.J. Adeno-associated virus vectors for gene therapy: more pros than cons? Mol. Med. Today. 6:2000;433-440.
29. Parker J.S., Parrish C.R. Cellular uptake and infection by canine parvovirus involves rapid dynamin-regulated clathrin-mediated endocytosis, followed by slower intracellular trafficking. J. Virol. 74:2000;1919-1930.
30. Basak S., Turner H. Infectious entry pathway for canine parvovirus. Virology. 186:1992;368-376.
31. Bartlett J.S., Wilcher R., Samulski R.J. Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors. J. Virol. 74:2000;2777-2785.
32. Vihinen-Ranta M., Yuan W., Parrish C.R. Cytoplasmic trafficking of the canine parvovirus capsid and its role in infection and nuclear transport. J. Virol. 74:2000;4853-4859.
33. Zadori Z., et al. A viral phospholipase A2 is required for parvovirus infectivity. Dev. Cell. 1:2001;291-302.
34. Cotmore S.F., D'Abramo A.M. Jr., Ticknor C.M., Tattersall P. Controlled conformational transitions in the MVM virion expose the VP1 N-terminus and viral genome without particle disassembly. Virology. 254:1999;169-181.
35. Chapman M.S., Rossmann M.G. Structure, sequence, and function correlations among parvoviruses. Virology. 194:1993;491-508.
36. Vihinen-Ranta M., Kalela A., Makinen P., Kakkola L., Marjomaki V., Vuento M. Intracellular route of canine parvovirus entry. J. Virol. 72:1998;802-806.
37. Weichert W.S., Parker J.S., Wahid A.T.M., Chang S.F., Meier E., Parrish C.R. Assaying for structural variation in the parvovirus capsid and its role in infection. Virology. 250:1998;106-117.
38. Vihinen-Ranta M., Kakkola L., Kalela A., Vilja P., Vuento M. Characterization of a nuclear localization signal of canine parvovirus capsid proteins. Eur. J. Biochem. 250:1997;389-394.
39. Vihinen-Ranta M., Wang D., Weichert W.S., Parrish C.R. The VP1 N-terminal sequence of canine parvovirus affects nuclear transport of capsids and efficient cell infection. J. Virol. 76:2002;1884-1891.
40. Morrison E.E., Stevenson A.J., Wang Y.-F., Meredith D.M. Differences in the intracellular localization and fate of herpes simplex virus tegument proteins early in the infection of Vero cells. J. Gen. Virol. 79:1998;2517-2528.
41. Morrison E.E., Wang Y.F., Meredith D.M. Phosphorylation of structural components promotes dissociation of the herpes simplex virus type 1 tegument. J. Virol. 72:1998;7108-7114.
42. LaBoissiere S., O'Hare P. Analysis of HCF, the cellular cofactor of VP16, in herpes simplex virus-infected cells. J. Virol. 74:2000;99-109.
43. O'Hare P. The virion transactivator of herpes simplex virus. Sem. Virol. 4:1993;145-155.
44. Zhou Z.H., Chen D.H., Jakana J., Rixon F.J., Chu W. Visualization of tegument-capsid interactions and DNA in intact herpes simplex virus type 1 virions. J. Virol. 73:1999;3210-3218.
45. Ojala P.M., Sodeik B., Ebersold M.W., Kutay U., Helenius A. Herpes simplex virus type 1 entry into host cells: reconstitution of capsid binding and uncoating at the nuclear pore complex in vitro. Mol. Cell. Biol. 20:2000;4922-4931.
46. Roizman B., Furlong D. The replication of herpesviruses. Fraaenkel-Conrat H., Wagner R.R. Comprehensive Virology. Vol. 3:1974;Plenum Press, New York.
47. Batterson W., Furlong D., Roizman B. Molecular genetics of herpes simplex virus. VIII. Further characterization of a temperature-sensitive mutant defective in release of viral DNA and in other stages of the viral reproductive cycle. J. Virol. 45:1983;397-407.
48. Enquist L.W., Husak P.J., Banfield B.W., Smith G.A. Infection and spread of alphaherpesviruses in the nervous system. Adv. Virus Res. 51:1998;237-347.
49. Kristensson K., Lycke E., Roytta M., Svennerholm B., Vahlne A. Neuritic transport of herpes simplex virus in rat sensory neurons in vitro. Effects of substances interacting with microtubular function and axonal flow [nocodazole, taxol and erythro-9-3-(2-hydroxynonyl)adenine]. J. Gen. Virol. 67:1986;2023-2028.
50. Sodeik B., Ebersold M.W., Helenius A. Microtubule-mediated transport of incoming herpes simplex virus 1 capsids to the nucleus. J. Cell Biol. 136:1997;1007-1021.
51. Miranda-Saksena M., Armati P., Boadle R.A., Holland D.J., Cunningham A.L. Anterograde transport of herpes simplex virus type 1 in cultured, dissociated human and rat dorsal root ganglion neurons. J. Virol. 74:2000;1827-1839.
52. Smith G.A., Gross S.P., Enquist L.W. Herpesviruses use bidirectional fast-axonal transport to spread in sensory neurons. Proc. Natl. Acad. Sci. USA. 98:2001;3466-3470.
53. Kann M., Lu X., Gerlich W.H. Recent studies on replication of hepatitis B virus. J. Hepatol. 22:1995;9-13.
54. Nassal M., Schaller H. Hepatitis B virus replication. Trends Microbiol. 1:1993;221-228.
55. Kann M., Bischof A., Gerlich W.H. In vitro model for the nuclear transport of the hepadnavirus genome. J. Virol. 71:1997;1310-1316.
56. Kann M., Sodeik B., Vlachoul A., Gerlich W.H., Helenius A. Phosphorylation-dependent binding of hepatitis B virus core particles to the nuclear pore complex. J. Cell Biol. 145:1999;45-55.
57. Kasamatsu H., Nakashini A. How do animal DNA viruses get to the nucleus? Annu. Rev. Microbiol. 52:1998;627-686.
58. Norkin L.C. Caveolae in the uptake and targeting of infectious agents and secreted toxins. Adv. Drug Deliv. Rev. 49:2001;301-315.
59. Pelkmans L.J.K., Helenius A. Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. Nat. Cell Biol. 3:2001;473-483.
60. Kartenbeck J., Stukenbrok H., Helenius A. Endocytosis of simian virus 40 into the endoplasmic reticulum. J. Cell Biol. 109:1989;2721-2729.
61. Chen Y., Norkin L.C. Extracellular simian virus 40 transmits a signal that promotes virus enclosure within caveolae. Exp. Cell Res. 246:1999;83-90.
62. Liddington R.C., Yan Y., Moulai J., Sahli R., Benjamin T.L., Harrison S.C. Structure of simian virus 40 at 3.8-A resolution. Nature. 354:1991;278-284.
63. Li M., Beard P., Estes P.A., Lyon M.K., Garcea R.L. Intercapsomeric disulfide bonds in papillomavirus assembly and disassembly. J. Virol. 72:1998;2160-2167.
64. Nakanishi A., Clever J., Yamada M., Li P., Kasamatsu H. Association with capsid proteins promotes nuclear targeting of simian virus 40 DNA. Proc. Natl. Acad. Sci. USA. 93:1996;96-100.
65. Clever J., Yamada M., Kasamatsu H. Import of simian virus 40 virions through nuclear pore complexes. Proc. Natl. Acad. Sci. USA. 88:1991;7333-7337.
66. Yamada M., Kasamatsu H. Role of nuclear pore complex in simian virus 40 nuclear targeting. J. Virol. 67:1993;119-130.
67. Griffith G.R., Marriot S.J., Rintoul D.A., Consilgi R.A. Early events in polyomavirus infection: fusion of monopinocytotic vesicles containing virions with mouse kidney cell nuclei. Virus Res. 10:1988;41-51.
68. An K., Paulsen A.Q., Tilley M.B., Consigli R.A. Use of electron microscopic and immunogold labeling techniques to determine polyomavirus recombinant VP1 capsid-like particles entry into mouse 3T6 cell nucleus. J. Virol. Methods. 90:2000;91-97.
69. Merle E., Rose R.C., LeRoux L., Moroianu J. Nuclear import of HPV11 L1 capsid protein is mediated by karyopherin alpha2beta1 heterodimers. J. Cell Biochem. 74:1999;628-637.
70. Nelson L.M., Rose R.C., LeRoux L., Lane C., Bruya K., Moroianu J. Nuclear import and DNA binding of human papillomavirus type 45 L1 capsid protein. J. Cell Biochem. 79:2000;225-238.
71. Liu W.J., Qi Y.M., Zhao K.N., Liu Y.H., Liu X.S., Frazer I.H. Association of bovine papillomavirus type 1 with microtubules. Virology. 282:2001;237-244.
72. Lewis P.F., Emerman M. Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J. Virol. 68:1994;510-516.
73. Berger E.A., Murphy P.M., Farber J.M. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu. Rev. Immunol. 17:1999;657-700.
74. Stevenson M. Portals of entry: uncovering HIV nuclear transport pathways. Trends Cell Biol. 6:1996;9-15.
75. Miller M.D., Farnet C.M., Bushman F.D. Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition. J. Virol. 71:1997;5382-5390.
76. Stevenson M. Molecular biology of lentivirus-mediated gene transfer. Trono D. Current Topics in Microbiology and Immunology: Lentiviral Vectors. Vol. 261:2002;1-30 Springer-Verlag, Berlin.
77. Cullen B.R. Journey to the center of the cell. Cell. 105:2001;697-700.
78. Sherman M.P., Greene W.C. Slipping through the door: HIV entry into the nucleus. Microbes Infect. 4:2002;67-73.
79. Bukrinsky M., et al. A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature. 365:1993;666-669.
80. Gallay P., Stitt V., Mundy C., Oettinger M., Trono D. Role of the karyopherin pathway in human immunodeficiency virus type 1 nuclear import. J. Virol. 70:1996;1027-1032.
81. Fouchier R.A.M., Meyer B.E., Simon J.H.M., Fischer U., Malim M.H. HIV-1 infection of non-dividing cells: evidence that the amino-terminal basic region of the viral matrix protein is important for Gag processing but not for post-entry nuclear import. EMBO J. 15:1997;4531-4539.
82. Haffar O.K., Popov S., Dubrovsky L., Agostini I., Tang H., Pushkarsky T., Nadler S.G., Bukrinsky M. Two nuclear localization signals in the HIV-1 matrix protein regulate nuclear import of the HIV-1 pre-integration complex. J. Mol. Biol. 299:2000;359-368.
83. Dupont S., Sharova N., DéHoratious C., Virbasius C.-M.A., Zhu X., Bukrinskaya A.G., Stevenson M., Green M.G. A novel nuclear export activity in HIV-1 matrix protein required for viral replication. Nature. 402:1999;681-685.
84. Depienne C., Roques P., Creminon C., Fritsch L., Casseron R., Dormont D., Dargemont C., Benichou S. Cellular distribution and karyophilic properties of matrix, integrase, and Vpr proteins from the human and simian immunodeficiency viruses. Exp. Cell Res. 260:2000;387-395.
85. Gallay P., Swingler S., Aiken C., Trono D. HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator. Cell. 80:1995;379-388.
86. Gallay P., Swingler S., Song J., Bushman F., Trono D. HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase. Cell. 83:1995;569-576.
87. Camaur D., Gallay P., Swingler S., Trono D. Human immunodeficiency virus matrix tyrosine phosphorylation: characterization of the kinase and its substrate requirements. J. Virol. 71:1997;6834-6841.
88. Bukrinskaya A.G., Ghorpade A., Heinzinger N.K., Smithgall T.E., Lewis R.E., Stevenson M. Phosphorylation-dependent human immunodeficiency virus type 1 infection and nuclear targeting of viral DNA. Proc. Natl. Acad. Sci. USA. 93:1996;367-371.
89. Jacqué J.-M., Mann A., Enslen H., Sharvo N., Brichacek B., Davis R., Stevenson M. Modulation of HIV-1 infectivity by MAPK, a virion-associated kinase. EMBO J. 17:1998;2607-2618.
90. Heinzinger N.K., et al. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc. Natl. Acad. Sci. USA. 91:1994;7311-7315.
91. Jenkins Y., McEntee M., Weis K., Greene W.C. Characterization of HIV-1 vpr nuclear import: analysis of signals and pathways. J. Cell Biol. 143:1998;875-885.
92. Popov S., et al. Viral protein R regulates nuclear import of the HIV-1 pre-integration complex. EMBO J. 17:1998;909-917.
93. Vodicka M.A., Koepp D.M., Silver P.A., Emerman M. HIV-1 Vpr interacts with the nuclear transport pathway to promote macrophage infection. Genes Dev. 12:1998;175-185.
94. Popov S., Rexach M., Ratner L., Blobel G., Bukrinsky M. Viral protein R regulates docking of the HIV-1 preintegration complex to the nuclear pore complex. J. Biol. Chem. 273:1998;13347-13352.
95. de Noronha C.M., Sherman M.P., Lin H.W., Cavrois M.V., Moir R.D., Goldman R.D., Greene W.C. Dynamic disruptions in nuclear envelope architecture and integrity induced by HIV-1 Vpr. Science. 294:2001;1105-1108.
96. Eckstein D.A., Sherman M.P., Penn M.L., Chin P.S., De Noronha C.M., Greene W.C., Goldsmith M.A. HIV-1 Vpr enhances viral burden by facilitating infection of tissue macrophages but not nondividing CD4+ T cells. J. Exp. Med. 194:2001;1407-1419.
97. Gallay P., Hope T., Chin D., Trono D. HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway. Proc. Natl. Acad. Sci. USA. 94:1997;9825-9830.
98. Pluymers W., Cherepanov S.D., De Celrq E., Debyser Z. Nuclear localization of human immunodeficiency virus type 1 integrase expressed as a fusion protein with green fluorescent protein. Virology. 258:1999;327-332.
99. Petit C., Schwartz O., Mammano F. The karyophilic properties of human immunodeficiency virus type 1 integrase are not required for nuclear import of proviral DNA. J. Virol. 74:2000;7119-7126.
100. Bouyac-Bertoia M., Dvorin J.D., Fouchier R.A., Jenkins Y., Meyer B.E., Wu L.I., Emerman M., Malim M.H. HIV-1 infection requires a functional integrase NLS. Mol. Cell. 7:2001;1025-1035.
101. Depienne C., Mousnier A., Leh H., Le Rouzic E., Dormont D., Benichou S., Dargemont C. Characterization of the nuclear import pathway for HIV-1 integras. J. Biol. Chem. 276:2001;18102-18107.
102. Zennou V., Petit C., Guetard D., Hehrbass U., Montagnier L., Charneau P. HIV-1 genome nuclear import is mediated by a central DNA flap. Cell. 101:2000;173-185.
103. Kemler I., Whittaker G., Helenius A. Nuclear import of microinjected influenza virus ribonucleoproteins. Virology. 202:1994;1028-1033.
104. Martin K., Helenius A. Transport of incoming influenza virus nucleocapsids into the nucleus. J. Virol. 65:1991;232-244.
105. Matlin K.S., Reggio H., Helenius A., Simons K. Infectious entry pathway of influenza virus in a canine kidney cell line. J. Cell Biol. 91:1981;601-613.
106. Hernandez L.D., Hoffman L.R., Wolfsberg T.G., White J.M. Virus-cell and cell-cell fusion. Annu. Rev. Cell Dev. Biol. 12:1996;627-661.
107. Bui M., Whittaker G., Helenius A. Effect of M1 protein and low pH on nuclear transport of influenza virus ribonucleoproteins. J. Virol. 70:1996;8391-8401.
108. Martin K., Helenius A. Nuclear transport of influenza virus ribonucleoproteins: the viral matrix protein (M1) promotes export and inhibits import. Cell. 67:1991;117-130.
109. O'Neill R.E., Jaskunas R., Blobel G., Palese P., Moroianu J. Nuclear import of influenza virus RNA can be mediated by viral nucleoprotein and transport factors required for protein import. J. Biol. Chem. 270:1995;22701-22704.
110. Wang P., Palese P., O'Neill R.E. The NPI-1/NPI-3 (karyopherin alpha) binding site on the influenza a virus nucleoprotein NP is a nonconventional nuclear localization signal. J. Virol. 71:1997;1850-1856.
111. Neumann G., Castrucci M.R., Kawaoka Y. Nuclear import and export of influenza virus nucleoprotein. J. Virol. 71:1997;9690-9700.
112. Stevens M.P., Barclay W.S. The N-terminal extension of the influenza B virus nucleoprotein is not required for nuclear accumulation or the expression and replication of a model RNA. J. Virol. 72:1998;5307-5312.
113. Weber F., Kochs G., Gruber S., Haller O. A classical bipartite nuclear localization signal on Thogoto and influenza A virus nucleoprotein. Virology. 250:1998;8-18.
114. Digard P., Elton D., Bishop K., Medcalf E., Pope A. Modulation of nuclear localization of the influenza virus nucleoprotein through interaction with actin filaments. J. Virol. 73:1999;2222-2231.
115. Bullido R., Gómez-Puertas P., Albo C., Portela A. Several protein regions contribute to determine the nuclear and cytoplasmic localization of the influenza A virus nucleoprotein. J. Gen. Virol. 81:2000;135-142.
116. Jakel S., Mingot J.M., Schwarzmaier P., Hartmann E., Gorlich D. Importins fulfil a dual function as nuclear import receptors and cytoplasmic chaperones for exposed basic domains. EMBO J. 21:2002;377-386.
117. Briese T., de la Torre J., Lewis A., Ludwig H., Lipkin W.I. Borna disease virus, a negative-strand RNA virus, transcribes in the nucleus of infected cells. Proc. Natl. Acad. Sci. USA. 89:1992;11486-11489.
118. Cubitt B., de la Torre J.C. Amantadine does not have antiviral activity against Borna disease virus. Arch. Virol. 142:1997;2035-2042.
119. Hallensleben W., Zocher M., Staehli P. Borna disease virus is not sensitive to amantadine. Arch. Virol. 142:1997;2043-2048.
120. Schwemmle M., Jehle C., Shoemaker T., Lipkin W.I. Characterization of the major nuclear localization signal of the Borna disease virus phosphoprotein. J. Gen. Virol. 80:1999;97-100.
121. Wolff T., Unterstab G., Heins G., Richt J.A., Kann M. Characterization of an unusual importin alpha binding motif in the borna disease virus p10 protein that directs nuclear import. J. Biol. Chem. 277:2002;12151-12157.
122. Staeheli P., Pavlovic J. Mx-proteins: GTPases with antiviral activity. Trends Cell Biol. 3:1993;268-272.
123. Kochs G., Haller O. GTP-bound human MxA protein interacts with the nucleocapsids of Thogoto virus (Orthomyxoviridae). J. Biol. Chem. 274:1999;4370-4376.
124. Dubrovsky L., Ulrich P., Nuovo G.J., Manogue K.R., Cerami A., Bukrinsky M. Nuclear localization signal of HIV-1 as a novel target for therapeutic intervention. Mol. Med. 1:1995;217-230.
125. Haffar O.K., Smithgall M.D., Popov S., Ulrich P., Bruce A.G., Nadler S.G., Cerami A., Bukrinsky M.I. CNI-H0294, a nuclear importation inhibitor of the human immunodeficiency virus type 1 genome, abrogates virus replication in infected activated peripheral blood mononuclear cells. Antimicrob. Agents Chemother. 42:1998;1133-1138.
126. Glushakova S., Dubrovsky L., Grivel J., Haffar O., Bukrinsky M. Small molecule inhibitor of HIV-1 nuclear import suppresses HIV-1 replication in human lymphoid tissue ex vivo: a potential addition to current anti-HIV drug repertoire. Antiviral Res. 47:2000;89-95.
127. Friedler A., Zakai N., Karni O., Broder Y.C., Baraz L., Kotler M., Loyter A., Gilon C. Backbone cyclic peptide, which mimics the nuclear localization signal of human immunodeficiency virus type 1 matrix protein, inhibits nuclear import and virus production in nondividing cells. Biochemistry. 37:1999;5616-5622.
128. Lei E.P., Silver P.A. Protein and RNA export from the nucleus. Dev. Cell. 2:2002;261-272.